EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo-Reference-Cited by-同舟云学术

EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo

Published:2020-01 Issue:5 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Xia Lin¹²,Zheng Zao‐zao¹,Liu Jun‐yi²,Chen Yu‐jie¹,Ding Jian‐cheng¹,Xia Ning‐shao²,Luo Wen‐xin²,Liu Wen¹²³

Affiliation:

1. Fujian Provincial Key Laboratory of Innovative Drug Target Research School of Pharmaceutical Sciences Xiamen University Xiamen China

2. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics National Institute of Diagnostics and Vaccine Development in Infectious Diseases School of Public Health School of Life Sciences Xiamen University Xiamen China

3. State Key Laboratory of Cellular Stress Biology School of Pharmaceutical Sciences Xiamen University Xiamen China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1135

Reference91 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Molecular portraits of human breast tumours

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

4. Triple-Negative Breast Cancer

5. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving immunotherapeutic solutions for triple-negative breast carcinoma;Cancer Treatment Reviews;2024-11

2. Emerging paradigms and recent progress in targeting ErbB in cancers;Trends in Pharmacological Sciences;2024-06

3. CDK7 in breast cancer: mechanisms of action and therapeutic potential;Cell Communication and Signaling;2024-04-11

4. Epidermal growth factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium;Redox Biology;2024-02

5. Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming Improvements;Molecular Cancer Therapeutics;2024-01-18